Press

Lessons from three decades of disruption

Today’s additive manufacturing industry is leaps and bounds from where it started. In the early to mid-1990s, the industry was called the “rapid prototyping industry,” and there were only a handful of companies developing 3D printers that could be used for engineering and design verification.

Bioinspired Intratumoral Infusion Port Catheter Improves Local Drug Delivery in the Liver

This technical paper published in Springer Nature introduces a bio-inspired intratumoral catheter, designed to keep medications exactly where they're needed in liver tumors. Fabricated using BMF’s projection micro stereolithography (PµSL) technology, the catheter includes 0.4 mm sideholes and finely detailed barbs, inspired by bee stingers, that secure it within the tumor.

Boston Micro Fabrication Opens Lab to Support Testing, Manufacturing and Sales of Zirconia UltraThineer Veneers

Boston Micro Fabrication (BMF), a leader in advanced manufacturing solutions for ultra-high precision applications, today opened the UltraThineer™ Lab at its U.S. headquarters in Maynard, Mass. to advance the production of UltraThineer veneers. The UltraThineer Lab will house BMF’s proprietary technology, projection micro stereolithography (PµSL), to custom manufacture cosmetic veneers that are three-times thinner than traditional veneers, enabling dentists to offer the world’s thinnest custom veneers to their patients in the U.S.

Additive Manufacturing-Assisted Casting of 3D Micro-Architected Heat Sinks

In a recent study led by Oraib Al-Ketan at New York University Abu Dhabi, Boston Micro Fabrication’s microArch S240 system played a key role in developing 3D micro-architected heat sinks to tackle modern thermal management challenges. By using AM-assisted casting and the precise 10µm XY resolution of the S240, the team created advanced heat sink designs that achieved up to 13% temperature reduction under forced convection. This method merges the design flexibility of additive manufacturing with casting’s scalability, offering effective cooling solutions for compact electronic devices.

John Kawola Discusses How 3D Printing is Driving Innovation Across Medicine

In his 20+ years in the 3D printing industry, our CEO John Kawola has seen firsthand how the technology is driving innovation, particularly in the medical field. He recently wrote an article for Medical Plastics News on how micro 3D printing is uniquely suited to solve medtech industry pain points, from compatibility with materials, the level of precision at a small size, and research & development. Read the article to learn more about 3D printing-led advancements across life sciences applications.

Full-Thickness Perfused Skin-on-a-Chip with In Vivo-Like Drug Response for Drug and Cosmetics Testing

The BMFBiotechnology team has been published by MDPI in Bioengineering! Their study presents a groundbreaking 3D full-thickness perfused skin-on-a-chip model, developed using BMF's micro-precision 3D printing technology. This innovative model replicates in vivo-like conditions, providing enhanced accuracy in drug response testing and offering a streamlined, high-throughput alternative to traditional skin models. It’s a major step forward in replicating the complex structure of human skin, with exciting potential for advancing dermatological, pharmaceutical, and cosmetic testing.

Inc. 5000 2024: Meet the Companies Building the Future

Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 through 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies--as of December 31, 2023. (Since the period under review, some on the list may have gone public or been acquired.) The minimum revenue required for 2020 is $100,000; the minimum for 2023 is $2 million. Growth rates used to determine rankings were calculated to four decimal places. All honorees must pass Inc. editorial review.